ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ProBioGen AG Appoints Dr. Lutz Hilbrich as New Chief Executive Officer - Dr. Wieland Wolf Retires
May 06, 2020ProBioGen AG, a premier, Berlin-based CDMO for developing and manufacturing complex therapeutic glycoproteins today announced that Dr. Lutz Hilbrich, an experienced biotech executive, has been named Chief Executive Officer, effective June 1, 2020. -
Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer
February 24, 2019Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases, announced the departure of the Chief Executive Officer and member of the Board of D
Pharma Sources Insight January 2025
